Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10964181 | Vaccine | 2015 | 10 Pages |
Abstract
Rotavirus vaccine introduction is highly cost-effective in both countries in a range of plausible 'what-if' scenarios. The involvement of national experts improves the quality of data used, is likely to increase acceptability of the results in decision-making, and can contribute to strengthened national capacity to undertake economic evaluations.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Charles Sigei, John Odaga, Mercy Mvundura, Yvette Madrid, Andrew David Clark, Kenya ProVac Technical Working Group Kenya ProVac Technical Working Group, Uganda ProVac Technical Working Group Uganda ProVac Technical Working Group,